[Federal Register Volume 70, Number 92 (Friday, May 13, 2005)]
[Notices]
[Page 25601]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-9574]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Inv. No. 337-TA-539]


In the Matter of Certain Tadalafil or Any Salt or Solvate 
Thereof, and Products Containing Same; Notice of Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Institution of investigation pursuant to 19 U.S.C. 1337.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that a complaint was filed with the 
U.S. International Trade Commission on April 8, 2005, under section 337 
of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of 
Lilly ICOS LLC of Wilmington, Delaware. A letter supplementing the 
complaint was filed on April 27, 2005. The complaint, as supplemented, 
alleges violations of section 337 in the importation into the United 
States, the sale for importation, and the sale within the United States 
after importation of certain tadalafil or any salt or solvate thereof, 
and products containing same, by reason of infringement of claims 1-4, 
6-8, and 12-13 of U.S. Patent No. 5,859,006. The complaint further 
alleges that there exists an industry in the United States as required 
by subsection (a)(2) of section 337.
    The complainant requests that the Commission institute an 
investigation and, after the investigation, issue a permanent general 
exclusion order and permanent cease and desist orders.

ADDRESSES: The complaint and supplemental letter, except for any 
confidential information contained therein, are available for 
inspection during official business hours (8:45 a.m. to 5:15 p.m.) in 
the Office of the Secretary, U.S. International Trade Commission, 500 E 
Street, SW., Room 112, Washington, DC 20436, telephone 202-205-2000. 
Hearing impaired individuals are advised that information on this 
matter can be obtained by contacting the Commission's TDD terminal on 
202-205-1810. Persons with mobility impairments who will need special 
assistance in gaining access to the Commission should contact the 
Office of the Secretary at 202-205-2000. General information concerning 
the Commission may also be obtained by accessing its Internet server at 
http://www.usitc.gov. The public record for this investigation may be 
viewed on the Commission's electronic docket (EDIS) at http://edis.usitc.gov.

FOR FURTHER INFORMATION CONTACT: Jay H. Reiziss, Esq., Office of Unfair 
Import Investigations, U.S. International Trade Commission, telephone 
202-205-2579.
    Authority: The authority for institution of this investigation is 
contained in section 337 of the Tariff Act of 1930, as amended, and in 
section 210.10 of the Commission's Rules of Practice and Procedure, 19 
CFR 210.10 (2004).
    Scope of Investigation: Having considered the complaint, the U.S. 
International Trade Commission, on May 9, 2005, Ordered that--
    (1) Pursuant to subsection (b) of section 337 of the Tariff Act of 
1930, as amended, an investigation be instituted to determine whether 
there is a violation of subsection (a)(1)(B) of section 337 in the 
importation into the United States, the sale for importation, or the 
sale within the United States after importation of certain tadalafil or 
any salt or solvate thereof, or products containing same, by reason of 
infringement of one or more of claims 1-4, 6-8, and 12-13 of U.S. 
Patent No. 5,859,006, and whether an industry in the United States 
exists as required by subsection (a)(2) of section 337.
    (2) For the purpose of the investigation so instituted, the 
following are hereby named as parties upon which this notice of 
investigation shall be served:
    (a) The complainant is--
    Lilly ICOS LLC, 1209 Orange Street, Wilmington, DE 19801.
    (b) The respondents are the following companies alleged to be in 
violation of section 337 and upon which the complaint is to be served:
Pharmacy4u.us, Attn: Dave Fox, 166 W. 44th Street, New York, NY 10282, 
Santovittorio Holdings Ltd, d/b/a Inhousepharmacy.co.uk.
Apartado 6-6305 El Dorado, El Dorado, Panama, Expressgeneric, 722 8th 
Cross, 11th Main H.A.L. 2nd Stage, Bangalore, Karnataka 560008 IN.
India, Stop4rx, Box 1246 Port-au-Prince, Port-au-Prince, FE 123182, 
Haiti.
Cutprice Pills, c/o Domains By Proxy, Inc., 15111 N. Hayden Road, Suite 
160, PMB353, Scottsdale, AZ 85260.
Allpills.us, Attn: Gerard Gibson, Madisson 12, Beverly Hills, CA 90210.
Generic Cialis Pharmacy, Del Parque Central 200 N, Managua, Nicaragua, 
Rx Mex-Com, S.A. de C.V., Avenida Lazaro Cardenas 4207, 
Colonia Las Brisas, Monterrey 64780, Mexico.
Budget Medicines Pty Ltd., 2 Brierwood Place, French's Forest, Sydney, 
2068, Australia.
www.nudewfds.info, 838 Camp Street, Apartment C, New Orleans, LA 70130.

(c) Jay H. Reiziss, Esq., Office of Unfair Import Investigations, U.S. 
International Trade Commission, 500 E Street, SW., Suite 401, 
Washington, DC 20436, who shall be the Commission investigative 
attorney, party to this investigation; and
    (3) For the investigation so instituted, the Honorable Charles E. 
Bullock is designated as the presiding administrative law judge.
    Responses to the complaint and the notice of investigation must be 
submitted by the named respondents in accordance with section 210.13 of 
the Commission's Rules of Practice and Procedure, 19 CFR 210.13. 
Pursuant to 19 CFR 201.16(d) and 210.13(a), such responses will be 
considered by the Commission if received no later than 20 days after 
the date of service by the Commission of the complaint and the notice 
of investigation. Extensions of time for submitting a response to the 
complaint will not be granted unless good cause therefor is shown.
    Failure of a respondent to file a timely response to each 
allegation in the complaint and in this notice may be deemed to 
constitute a waiver of the right to appear and contest the allegations 
of the complaint and to authorize the administrative law judge and the 
Commission, without further notice to the respondent, to find the facts 
to be as alleged in the complaint and this notice and to enter both an 
initial determination and a final determination containing such 
findings, and may result in the issuance of a limited exclusion order 
or a cease and desist order or both directed against such respondent.

    By order of the Commission.

    Issued: May 9, 2005.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 05-9574 Filed 5-12-05; 8:45 am]
BILLING CODE 7020-02-P